Topical treatment of anogenital human papillomavirus infection in male patients

Author： Ankerst Donna P   Diepolder Helmut   Horster Sophia  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.4, Iss.6, 2009-11, pp. : 531-541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers

By  

Journal of Digestive Diseases, Vol. 16, Iss. 5, 2015-05 ,pp. : 256-263

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biphasic Vesicles for Topical Delivery of Interferon Alpha in Human Volunteers and Treatment of Patients with Human Papillomavirus Infections

By  

Current Drug Delivery, Vol. 8, Iss. 3, 2011-05 ,pp. : 307-319

Bentham Science Publishers

Access to resources Recommend Favorite

What is the best treatment for patients with human papillomavirus–positive and –negative oropharyngeal cancer?

By Urban Damien   Corry June   Rischin Danny  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1462-1470

Blackwell Publishing

Access to resources Recommend Favorite

Emerging therapies for human papillomavirus infection

By Wilson Francis X  

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 199-207

Informa Healthcare

Access to resources Recommend Favorite

Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US: Analytic Framework and Review of the Literature

By Insinga Ralph P.   Dasbach Erik J.   Elbasha Elamin H.  

PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. : 1107-1122

Adis International

Access to resources Recommend Favorite